Accessing Retatrutide in Canada Retatrutide is not yet approved by Health Canada or the FDA
Blood samples were collected into eppendorfs containing DPPIV inhibitor (Millipore, Abingdon, Oxfordshire, UK
Your pathway to optimization includes a baseline InBody composition analysis, vital signs, and blood work
While traditional GLP-1 agonists focus on a single pathway, retatrutide functions as a triple agonist, integrating signals from three distinct metabolic receptors: GLP-1: Associated with slowed gastric emptying, appetite modulation, and glucose-dependent insulin secretion
The Role of GLP-1s in Metabolic Health PLUS Potential Benefits of Microdosing for Autoimmune Disease and Inflammation: A Functional Medicine Perspective Functional medicine, with its holistic approach to health, often focuses on understanding the root causes of chronic disease rather than merely addressing symptoms
If you don't lose 5% of your weight after 12 weeks of taking Contrave, your doctor may tell you to stop taking it because it's unlikely to work for you, the FDA says